A Device for Assured, Accurate Oxygen Flow Rates

Sales of OxyView from Ingen Technologies, Inc. to the medical market began in February. It's a patent pending product that provides a greater degree of certainty about oxygen flow rates for patients using oxygen during surgery, hospitalization and outpatient oxygen therapy.

Sales of OxyView from Ingen Technologies, Inc. to the medical market began in February. It's a patent pending product that provides a greater degree of certainty about oxygen flow rates for patients using oxygen during surgery, hospitalization and outpatient oxygen therapy. The device is a disposable pneumatic analog guague that accurately measures the oxygen flow rate between the source and the patient.

"There are over 5,000 oxygen canula's used every day in hospitals and surgical room," notes Chris Wirth, director of Ingen Technologies. "Many patients are using oxygen as outpatient therapy for a variety of pulmonary diseases. Hospitals and surgical staff are required to dispose of the units to meet OSHA regulations. OxyView is a product that's clean-packaged and disposable."

OxyView is a pneumatic gauge that provides visual safety warning of oxygen flow to hospitalized patients. It is designed to enhance the safety, assurance and accuracy of hospitalized patients being administered oxygen from any source. The device is attached to the oxygen tubing just below the neck. It informs staff of oxygen flow rate and may quickly indicate any leak or inaccuracy between the delivery source and patient.

Ingen feels that with its current distribution setup and strategic advertising, OxyView will penetrate some 10% of the market through the remainder of the year. It expects $2.8 million in revenues from hospitals and surgical facilities and an additional $12 million from sales to oxygen suppliers and medical supply chains for patients using outpatient therapy.

March 2006
Explore the March 2006 Issue

Check out more from this issue and find your next story to read.